Prof. Andrew Bush is the Professor of Paediatrics and Head of Section (Paediatrics), Imperial College, Professor of Paediatric Respirology, National Heart and Lung Institute, and Consultant Paediatric Chest Physician, Royal Brompton Hospital, London UK. He is also Editor in Chief of Thorax, with Professor Ian Pavord.
His main research interests are the invasive and non-invasive assessment of airway inflammation, paediatric clinical physiology, and orphan lung diseases.
See more info about Prof. Andrew Bush here
Andrew A. COLIN
Andrew Colin, MD is the Batchelor Professor of Cystic Fibrosis and Pediatric Pulmonology and Chief of the Division of Pediatric Pulmonology, Miller School of Medicine of the University of Miami. He has continually held leadership positions with the International Congresses of Pediatric Pulmonology (CIPP) and served as the President of its 10th and 11th Congresses.
Professor Colin completed fellowships in pediatric pulmonology at Hadassah Medical Center in Jerusalem and Boston Children’s Hospital/Harvard Medical School. He remained at Harvard for 15 years ranked Associate Professor, and at Boston Children’s Hospital served as Clinical Chief of the pulmonary program, he was also in charge of the Pediatric Pulmonary Clerkship of Harvard Medical School.
Dr. Colin published extensively and presented nationally and internationally in areas of his interest: structural and functional development and morbidity of the respiratory system with related physiological measurements, including lung diseases of late prematurity, infants with CF and HIV. Pediatric bronchoscopy. Infectious and inflammatory diseases of the lung. Pediatric Radiology.
He directs the fellowship training program at the University of Miami and trained some 60 fellows in pediatric pulmonology. In 2017, he became the first ever recipient of “PEDS Lifetime Contributions to Pediatric Respiratory Medicine Award” of the ATS Assembly on Pediatrics. At Harvard, he received a Pulmonology Teaching Award named after him, as well as the 2004 Klaus Peter International Teaching Award. He has been named Honorary Fellow of the pediatric pulmonary societies of Philippines, Hong Kong and Thailand.
R. Paul GUILLERMAN
R. Paul Guillerman is Professor of Radiology at the Baylor College of Medicine and Chief of Academic Affairs in the Department of Pediatric Radiology at Texas Children’s Hospital in Houston, Texas. His clinical and research interests include imaging of pediatric diffuse lung diseases, chest CT technique optimization, risk assessment and communication. He has given over 130 invited lectures, authored or co-authored over 80 medical journal articles and textbook chapters, and co-edited the latest edition of the Springer textbook Pediatric Chest Imaging. He is co-director of the Center for Diagnostic Imaging of the Cystic Fibrosis Foundation (CFF) Therapeutic Development Network. He has served as a member of the CFF Preschool Age Screening and Monitoring Workgroup, Children’s Interstitial Lung Disease Research Network (ChILDRN), Image Gently Steering Committee and Speakers Group, Society for Pediatric Radiology (SPR) Research & Education Board of Directors, SPR CT and Thoracic Imaging Committees, and ACR-SCBT-MR-SPR Practice Guideline for the Performance of Thoracic CT Committee.
Prof. Eitan Kerem, MD, a world known leader in Cystic Fibrosis research, is a principal investigator of numerous national and international multicenter clinical trials. He is the author of seminal publications in the field, including phenotype-genotype relationships, disease prognostic factors, the molecular mechanisms for disease variability, and the development of novel mutation-specific pharmacological therapies to correct the basic defects in cystic fibrosis.
His many interests extend beyond cystic fibrosis, and he has been central to studies examining environmental interactions with genetic diseases and its influence on the disease severity, genetic markers of asthma and allergy in closed populations, and variability of disease in closed populations exposed to different environments. Increasingly, his efforts have turned to understanding the genetics of primary ciliary dyskinesia in Jewish and Palestinian children. In addition he published leading papers on management of community acquired pneumonia in children and was the first to characterize nectrotizing pneumonia and risk factors for complicated pneumonia in children.
The promotion of the medical, ethical and rights aspects of children with chronic diseases is at the forefront of his interest. He published many papers in this field and is known for his advocacy for children in need.
He also has a record of building bridges between Israelis and Palestinians furthering peace through medicine wherever possible.
Professor Kerem received a number of prestigious awards the last being the European CF Society Award in 2014.
He has authored over 170 papers covering all aspects of Pulmonology.
Prof. Amir Kugelman is a Clinical Associate Professor of Pediatrics in The R&B Rappaport Faculty of Medicine, Technion, Haifa, Israel. He specialized in Pediatric Pulmonology and Neonatology in Children’s Hospital, LA, CA, and is currently the Director of the Department of Neonatology in Rambam Medical Center, Haifa, Israel and the past Chairman of the Israeli Society of Pediatric Pulmonology.
His main research is in Neonatal Pulmonology, focusing on non- invasive ventilation, non-invasive respiratory monitoring in the NICU and the Pediatric Department, and in the prevention and treatment of Chroric Lung Disease of premature infants. Other areas of interest and research: Iatrogenesis in NICUs, late preterm infants, outcome of VLBW infants, and delayed cord clamping in the delivery room.
Fernando D. MARTINEZ
Dr. Fernando D. Martinez is a Regents’ Professor and Director of the Asthma & Airway Disease Research Center at the University of Arizona in Tucson.
Dr. Martinez is a world-renowned expert, and one of the most highly regarded researchers, in the field of childhood asthma. His primary research interests are the natural history, genetics, and treatment of childhood asthma.
His groundbreaking research has had an impact on his field in numerous ways, most prominent among them the development of the concept of the early origins of asthma and COPD. This concept is now widely accepted as the potential basis for the design of new strategies for the prevention of these devastating illnesses affecting millions of children and adults worldwide. In addition, Dr. Martinez has made important contributions to our understanding of the role of gene-environment interactions in the development of asthma and allergies. He has also been the principal investigator of one of the Clinical Centers that are part of the NHLBI Asthma Treatment Networks, which have contributed fundamental new evidence on which to base national guidelines for the treatment of the disease.
Dr. Martinez currently serves on national scientific boards including the NHLBI National Advisory Council and the National Scientific Council on the Developing Child. He was a member of the National Asthma Education and Prevention Program that was responsible for the development of the Expert Panel Report: Guidelines for the Diagnosis and Management of Asthma in 1997 and its first revision in 2001. He also has been a member of the FDA Pulmonary-Allergy Drugs Advisory Committee and the Board of Extramural Advisors of the National Heart, Lung, and Blood Institute (NHLBI).
Dr. Martinez’s research and vision are well detailed in more than 250 original research papers and editorials, many in collaboration with investigators from all over the world. He is frequently invited to give keynote presentations at national and international meetings.
Prof. Jean-Paul Praud is a Pediatric Pulmonologist at the Sherbrooke University Hospital, Quebec, Canada, and Director, Center for Research into Maternal and Child Health, University of Sherbrooke. He holds the Canada Research Chair in Neonatal Respiratory Physiology since 2009.
He was co-founder of CIPP and Past-President, CIPP V. He has been President, ICPP-The Course, since 2007. He was a member of the Central Organizing Committee of all CIPP meetings and ICPP-Courses.
He is internationally renowned for his unique research contributions in the field of neonatal respiration, nasal respiratory support and sleep apneas.
Giovanni A. Rossi is the former chief of the Pulmonary and Allergy Units and of the Cystic Fibrosis Centre at the G. Gaslini Research Institute and University Hospital in Genoa and the former adjunct Professor of Paediatric Pulmonology at the University of Genoa, Italy. He is at present Chief Emeritus at the Gaslini Research Institute and University Hospital.
He graduated from the University of Genoa, Italy and trained in Respiratory Medicine at the San Martino University Hospital, in Genoa, and then at the Pulmonary Branch of the National Institutes of Health in Bethesda, U.S.A., as Visiting Associate.
Dr. Rossi was Member of the Executive Committee of the Société Européenne de Physiologie Clinique Respiratoire, Chairman of the “Lung Cell Biology” Assembly of the European Respiratory Society (ERS), Member of the ERS Executive Committee, society of which he has been recently appointed “Foundation Fellow”. He also served as an Associate Editor on the Editorial Boards of several respiratory, allergy and pediatric journals. He has published >300 manuscripts in peer reviewed journals and has at present a H. index of 52.
Dr. Rossi’s major areas of basic and clinical research have been the mechanisms involved in the pathogenesis of a variety of respiratory disorders, including interstitial, obstructive and infectious diseases. In this last field, his work has focused mainly on the characterization of the host-virus interaction at lower respiratory tract level, with the aim of developing novel strategies for the prevention and treatment of these high-impact respiratory disorders for which specific therapies are often not yet available.
Bruce K. RUBIN
Prof. Bruce Rubin is the Jessie Ball duPont Distinguished Professor and Chair of Pediatrics at Virginia Commonwealth University in Richmond, Virginia and Physician in Chief of the Children’s Hospital of Richmond. He is also Professor of Biomedical Engineering and Adjunct Professor of Physiology and Biophysics at VCU. Prof Rubin is a pediatric pulmonary physician and a Fellow of the Royal Society of Physicians of Canada (FRCPC). As a Rhodes Scholar, he trained as a post doc in Biomedical Engineering at Oxford University and in Paediatric Respirology at Sick Kids in Toronto. He holds the MD and Masters in Engineering degrees from Tulane and an MBA degree from Wake Forest University School of Business.
Dr. Rubin received the 2008 Forrest M. Bird Lifetime Scientific Achievement Award, the top research honor given by the American Association for Respiratory Care (AARC), in 2011 he presented the Phil Kittredge Memorial Keynote lecture at the AARC in 2012, he was awarded Jimmy Young Memorial medal from the AARC. He holds honorary appointments in 4 medical schools. He is on the editorial board of 12 medical journals, has published more than 300 original research papers and chapters and holds nine patents. Dr. Rubin and his research team study aerosol therapy for lung diseases, airway inflammation and excessive mucus that contributes to lung disease.
He is also an accomplished magician, an elected member of the International Brotherhood of Magicians, and over the past 25 years had taught medical magic in 30 countries on 5 continents.